Time-dependent changes and potential mechanisms of glucose-lipid metabolic disorders associated with chronic clozapine or olanzapine treatment in rats
Abstract Chronic treatment with second-generation antipsychotic drugs (SGAs) has been associated with an increased risk of metabolic syndrome. To evaluate the longitudinal changes in glucose-lipid homeostasis after SGA use, we studied the time-dependent effects of olanzapine (OLZ) (3 mg/kg, b.i.d.)...
Guardado en:
Autores principales: | Xuemei Liu, Zhixiang Wu, Jiamei Lian, Chang-Hua Hu, Xu-Feng Huang, Chao Deng |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d44ba3620fcd44e58ea44ad0872f6987 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Comparison of the Effects of Clozapine, Olanzapine and Risperidone with Haloperidol on Fasting Blood Level of Glucose, Cholesterol and Triglyceride in Patients with Psychotic Disorders
por: A Masoudzadeh, et al.
Publicado: (2009) -
Interaction of clozapine with metformin in a schizophrenia rat model
por: G. Horvath, et al.
Publicado: (2021) -
Olanzapine induced reproductive toxicity in male rats
por: Cankız Mina Ardıç, et al.
Publicado: (2021) -
Acupuncture for glucose and lipid metabolic disorders of polycystic ovarian syndrome: A systematic review protocol.
por: Yang Wu, et al.
Publicado: (2021) -
Effects of treatment with haloperidol and clozapine on the plasma concentrations of thyroid hormones in rats
por: Samadi Afshin, et al.
Publicado: (2020)